Business Standard

Monday, December 23, 2024 | 08:12 PM ISTEN Hindi

Notification Icon
userprofile IconSearch

J&J loses motion to overturn $4.7 billion talc-ovarian cancer verdict

The motion was aimed at getting a verdict that awarded $4.7 bn to women who blamed ovarian cancer on asbestos in the company's Baby Powder and other talc products reversed

Johnson & Johnson

The Johnson and Johnson logo is seen at an office building in Singapore | Photo: Reuters

Reuters

Healthcare conglomerate Johnson & Johnson has lost its motion to reverse a verdict that awarded $4.7 billion to women who blamed ovarian cancer on asbestos in the company's Baby Powder and other talc products, a Missouri court ruled on Wednesday.  
 

Shares of the company reversed course to slip 0.6 per cent to $129.38 in afternoon trading.  

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Dec 19 2018 | 11:37 PM IST

Explore News